Lpl Financial LLC Taro Pharmaceutical Industries LTD Transaction History

Lpl Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$47.6 - $65.0 $220,959 - $301,730	-4,642 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$62.34 - $73.38 $13,901 - $16,363	223 Added 5.05%	4,642 $295,000
Q2 2021 Aug 13, 2021	BUY	$70.26 - $76.64 $6,815 - $7,434	97 Added 2.24%	4,419 $318,000
Q1 2021 May 14, 2021	BUY	$70.48 - $79.95 $37,636 - $42,693	534 Added 14.1%	4,322 $319,000
Q4 2020 Feb 12, 2021	SELL	$54.4 - $73.42 $26,547 - $35,828	-488 Reduced 11.41%	3,788 $278,000

Q3 2020 Nov 09, 2020	SELL	$54.41 - $68.2 $5,223 - $6,547	-96 Reduced 2.2%	4,276 $235,000
Q2 2020 Aug 13, 2020	SELL	$61.66 - $70.16 $48,033 - $54,654	-779 Reduced 15.12%	4,372 $291,000
Q1 2020 May 14, 2020	SELL	$59.35 - $88.73 $11,276 - $16,858	-190 Reduced 3.56%	5,151 $315,000
Q4 2019 Feb 14, 2020	SELL	$74.18 - $97.92 $10,311 - $13,610	-139 Reduced 2.54%	5,341 $470,000
Q3 2019 Nov 13, 2019	SELL	$75.36 - $86.57 $33,233 - $38,177	-441 Reduced 7.45%	5,480 $413,000
Q2 2019 Aug 09, 2019	BUY	$83.92 - $108.88 $496,890 - $644,678	5,921 New	5,921 $506,000

4.64M

6.3K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.